Compare NUVB & HMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NUVB | HMN |
|---|---|---|
| Founded | 2018 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2020 | 1996 |
| Metric | NUVB | HMN |
|---|---|---|
| Price | $4.50 | $46.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | $13.00 | ★ $56.50 |
| AVG Volume (30 Days) | ★ 5.0M | 251.0K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 3.11% |
| EPS Growth | ★ 71.56 | 57.26 |
| EPS | N/A | ★ 2.01 |
| Revenue | $62,902,000.00 | ★ $1,701,400,000.00 |
| Revenue This Year | $209.36 | $3.85 |
| Revenue Next Year | $41.60 | $17.18 |
| P/E Ratio | ★ N/A | $23.03 |
| Revenue Growth | ★ 698.96 | 6.66 |
| 52 Week Low | $3.92 | $41.29 |
| 52 Week High | $9.75 | $55.56 |
| Indicator | NUVB | HMN |
|---|---|---|
| Relative Strength Index (RSI) | 31.70 | 46.00 |
| Support Level | $4.45 | $41.72 |
| Resistance Level | $5.16 | $46.75 |
| Average True Range (ATR) | 0.24 | 0.86 |
| MACD | 0.02 | 0.24 |
| Stochastic Oscillator | 16.78 | 46.59 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.